CRLComplete Response Letter
Complete Response Letter Spes Pharmaceuticals Inc. (Oct 19, 2022)
FDA's complete response letter contains source-text evidence related to Labeling, packaging, and proprietary name, Facility inspection and CGMP compliance. Theme counts identify where the letter discusses a topic; they do not replace review of the exact redacted letter.
Issued
US FDA• FOCINVEZ
